Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Biofrontera presents a novel antibiotic with anti-H. pylori activity

Oct. 20, 2004

HepeX-C reduces viral levels in patients with chronic HCV infection

Oct. 18, 2004

Enrollment opens in phase II study of MX-3253

Oct. 18, 2004

European orphan drug designation for TheraCLEC

Oct. 15, 2004

Antibody therapy promising against C. difficile

Oct. 14, 2004

Novel gastric antisecretory agents discovered at Altana

Oct. 14, 2004

Target enrollment reached in phase II study of methylnaltrexone for POI

Oct. 11, 2004

Six-month priority review for Pegasys sBLA

Oct. 11, 2004

A product derived from bovine colostrum reduces the effects of HIV-associated diarrhea

Oct. 11, 2004

Infliximab reported to reduce pain associated with Crohn's disease

Oct. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...